drugset / Trial / NCT05638633
Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Phase 3
Completed
321 enrolled
Wuerzburg University Hospital
University Hospital Schleswig-Holstein · collabUniversity Hospital Tuebingen · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, placebo controlled, double-blind phase III trial with four parallel groups studying studying the feasibility of RCT in primary care as well as the effectiveness of treatment with prednisolone and/or vitamin B1/6/12 for PC19S.
Timeline
- Start
- 2022-11-11
- Primary completion
- 2025-01-30
- Completion
- 2025-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prednisolone | Other / unclassified | 5 mg | — |
| Comparator | Vitamin B compound | Unknown | 500 ug | — |
| Comparator | Vitamin B compound | Unknown | 50 mg | — |
| Comparator | Vitamin B compound | Unknown | 100 mg | — |